Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib with Chemoradiation in Stage IIIA/B NSCLC
NCT00280787Phase 2Completed
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Nov 2003
- Primary completion
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in non-small cell lung cancer (NSCLC), sponsored by UNC Lineberger Comprehensive Cancer Center. Started Nov 2003; status: completed.
02
Drugs
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00280787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00280787.